Abstract
Background
The inverse correlation between the complexity of a drug regimen and medication adherence is well established. Fixed-dose combination (FDC) therapies are hypothesized to enhance compliance by decreasing the number of required pills.
Objective
The objective of the study is to compare adherence of a FDC [Glucovance®, a FDC of metformin and glyburide] to a 2-pill regimen.
Design
Longitudinal data from a large claims database were used to assess adherence from January 1, 2000, to December 31, 2001. Propensity scoring methods were used to mitigate concerns related to non-random assignment of patients to treatments.
Subjects
The subjects of the study were individuals prescribed metformin or sulfonylurea or both before July 2000, who were prescribed both metformin and sulfonylurea concurrently (either separately or FDC) after August 2000.
Measurements
Adherence was measured by medication possession ratio; the proportion of days on which a patient had medication available.
Results
The FDC enhanced adherence rates by approximately 13% when compared to a 2-pill regimen.
Conclusions
Compared to 2-pill therapy, a FDC resulted in important increases in patient adherence. Economic analyses are warranted to determine whether the clinical benefits attributable to the adherence gains are worth the incremental cost of a FDC.
This is a preview of subscription content, log in via an institution to check access.
References
McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a medicaid population. Med Care. 1994;32(3):214–6.
Cantrell C, Eaddy MT, Shah MB, Regan TS, Sokol MC. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care. 2006;44(4):300–3.
Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–42.
Wertheimer AI, Morrison A. Combination drugs: innovation in pharmacotherapy. P&T. 2002;27(1):44–9.
Leichter SB, Thomas S. Combination medications in diabetes care: an opportunity that merits more attention. Clin Diabetes. 2003;21(4):175–8.
Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care. 2000;9(9):2–6.
Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther. 2002;24(3):460–7.
Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55.
Bryson CL, Au DH, Young B, McDonell MB, Finh SD. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care. 2007;45(6):497–504.
Perkins SM, Tu W, Underhill MG, et al. The use of propensity scores in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2000;9:93–101.
Dehejia RH, Wahba S. Propensity score-matching methods for nonexperimental causal studies. Rev econ stat. 2002;84(1):151–61.
Acknowledgment
The authors received neither internal nor external funding for the work represented in this manuscript.
Conflict of Interest Statement
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pan, F., Chernew, M.E. & Fendrick, A.M. Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications. J GEN INTERN MED 23, 611–614 (2008). https://doi.org/10.1007/s11606-008-0544-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-008-0544-x